“…The focus in developed countries shifted from descriptions of the effect of HIV on the CNS to documenting the extent of neurological and developmental impairment (Belman, et al, 1996;Gay, et al, 1995;Lobato, et al, 1995;and European Collaborative Study, 1990). Improvements in methodology to support this aim included: longitudinal design; smaller age ranges from birth to four years with increased sample sizes (Belman, et al, 1996;Pollack, et al, 1996;Chase, et al, 1995;Gay, et al, 1995;Mellins, et al, 1994;Nozyce, Hittelman, et al, 1994;Condini, et al, 1991;and, European Collaborative Study, 1990); employing the use of the BSID-I, a standardised assessment tool (Belman, et al, 1996;Pollack, et al, 1996;Chase, et al, 1995;Gay, et al, 1995;Mellins, et al, 1994;and, Nozyce, Hittelman, et al, 1994); introduction of control groups (Belman, et al, 1996;Pollack, et al, 1996;Chase, et al, 1995;Gay, et al, 1995;Mellins, et al, 1994;Nozyce, Hittelman, et al, 1994;Condini, et al, 1991;European Collaborative Study, 1990;and Diamond, et al, 1990); and minimising confounding factors (Belman, et al, 1996).…”